YpsoPump – The intuitive insulin pump system
YpsoPump – The intuitive insulin pump system

Press Releases Ypsomed Canada

Burgdorf – Ypsomed Canada, a subsidiary of Ypsomed A.G has received Health Canada approval for the YpsoPump insulin pump. The market entry in Canada is another important milestone in the consistently pursued global growth strategy of the parent company.

Copaxone PEN from Teva
Copaxone PEN

Press Releases Ypsomed Group

Burgdorf – Teva Pharmaceutical Industries Ltd. (Teva), a global leader in generic medicines with innovative treatments in select areas, including CNS, pain and respiratory, has launched its drug product Copaxone® in the pre-filled autoinjector YpsoMate® from Ypsomed. Copaxone® is used for the treatment of patients with relapsing forms of multiple sclerosis (MS). The collaboration with Teva marks the second commercial market entry of Ypsomed’s autoinjector YpsoMate®.